Overview

Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks

Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
RCT to evaluate possible pharmacokinetic differences between the two current regimes of intensified adalimumab administration.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Universitario La Paz
Treatments:
Adalimumab